Without insurance, genetic testing for Alzheimer's risk usually costs about $149 for a direct-to-consumer APOE test. APOE is a gene with variants that raise or lower late-onset Alzheimer's risk. That base price covers a simple risk test, not a doctor visit or full dementia workup.
More complete kits and clinician-ordered panels cost more. Self-pay shoppers choose between low-cost swab tests and higher-priced panels. Price reflects what is tested, how fast results return, and whether counseling is included. Knowing those trade-offs helps you avoid paying for more than you need.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does a $149 test include?
- Why do some mail-order kits cost near $200?
- When does testing cost $399 or more?
- Will insurance cover predictive APOE testing?
What does a $149 test include?
A $149 test usually checks your APOE status from saliva or a cheek swab. HealthLabs lists its Alzheimer's Risk Assessment APOE test at $149 with results in 1-3 days, according to HealthLabs pricing. Life Extension sells a cheek-swab ApoE Genetic Test for Alzheimer's and cardiac risk for $149 without insurance billing, according to Life Extension's test listing.
These tests report risk-related gene types, not a diagnosis. They do not measure memory, amyloid, or current disease. They work best for healthy adults who want basic risk information.
Why do some mail-order kits cost near $200?
Some consumer kits bundle Alzheimer's risk with ancestry or other health reports. 23andMe's Health + Ancestry kit is priced at $199 and includes a late-onset Alzheimer's report as a consumer service not covered by insurance. Genetrace lists its Alzheimer's Disease DNA Test at $195 with a slower 4-6 week turnaround.
The higher price buys a broader product or different lab process. Turnaround, sample type, report detail, and customer support also differ. Compare the report sample before paying extra.
When does testing cost $399 or more?
Clinician-ordered and multi-gene options cost substantially more. GeneStreet lists its 35-gene Parkinson-Alzheimer-Dementia Panel at $600, while Quest's AD-Detect Alzheimer's blood tests start at $399. BetterBrain charges $149 for APOE genotyping as an add-on to its $399 Blueprint assessment, and says insurance never covers the APOE add-on.
These services may include medical ordering, broader gene coverage, or blood-based Alzheimer's markers. They can also add counseling or follow-up testing. Predictive genetic testing generally ranges from $150 to $2,000 overall, with price driven by complexity, lab, counseling, and clinical versus direct-to-consumer format, according to BuzzRx's medically reviewed cost guide.
Will insurance cover predictive APOE testing?
For healthy people seeking future risk, usually no. APOE predictive testing is generally not covered and is discouraged by guidelines.
ACMG advises against ordering APOE testing as a predictive test, while Medicare limits payment mainly to treatment decisions such as anti-amyloid drugs. Before ordering, take these practical steps: If cost is the main barrier, start with a $149 APOE test rather than a large panel. BetterBrain's example shows the add-on trap: a $399 assessment plus a never-covered $149 APOE fee, according to BetterBrain's pricing page.
- Decide whether you want APOE-only risk or broader dementia testing.
- Check whether the price includes physician ordering, shipping, and counseling.
- Ask about result timing, privacy practices, and access to raw data.
- Talk with your clinician if results could affect anxiety, family planning, or treatment choices.
You Might Also Like
- How Does Hearing and Vision Loss Together Relate to Dementia Risk With a Family History of Alzheimer’s?
- Hypertension in Midlife and Dementia Risk With a Family History of Alzheimer’s: What Evidence Supports
- How to Address Hypertension in Midlife in a Dementia Risk Plan With a Family History of Alzheimer’s
